Machine learning platform predicts, detects and monitors chronic disease across patient populations. Former WPC Healthcare/Intermedix executives, Ray Guzman and Damian Mingle, named advisors for new platform.
About IQuityThis author has not yet filled in any details.
So far IQuity has created 6 blog entries.
According to the American Autoimmune Related Diseases Association, autoimmune diseases are among the most prevalent diseases in the U.S., affecting approximately 50 million Americans — or 20 percent of the population. Among the 80–100 different types of autoimmune diseases [...]
IQuity is developing a health-care analytics platform that will mine large databases to predict and monitor chronic disease across large populations, transforming the company from a genomics test-maker to an "integrated data science company."
IQuity, an integrated data-sciences company in Nashville, said it has added to its bench healthtech advisors Ray Guzman and Damian Mingle, both previously with WPC Healthcare, which recently sold to Intermedix. IQuity, led by CEO Chase Spurlock PhD, recently launched a new data analytics platform.
IQuity, a data analytics company, announced the launch of an analytics platform that uses machine learning to predict, identify, and monitor chronic disease within large populations of patients, including multiple sclerosis (MS). The platform was validated using a pilot study that assessed the healthcare claims of 20 million people in New York, which encompassed four billion data points. IQuity focused on using these data to predict the onset of MS.
IQuity, a Nashville-based data analytics company that specializes in predicting, detecting and monitoring chronic disease, today announced the launch of a revolutionary data mining and analytics platform that will predict and monitor chronic diseases within large populations.